<code id='1110532E91'></code><style id='1110532E91'></style>
    • <acronym id='1110532E91'></acronym>
      <center id='1110532E91'><center id='1110532E91'><tfoot id='1110532E91'></tfoot></center><abbr id='1110532E91'><dir id='1110532E91'><tfoot id='1110532E91'></tfoot><noframes id='1110532E91'>

    • <optgroup id='1110532E91'><strike id='1110532E91'><sup id='1110532E91'></sup></strike><code id='1110532E91'></code></optgroup>
        1. <b id='1110532E91'><label id='1110532E91'><select id='1110532E91'><dt id='1110532E91'><span id='1110532E91'></span></dt></select></label></b><u id='1110532E91'></u>
          <i id='1110532E91'><strike id='1110532E91'><tt id='1110532E91'><pre id='1110532E91'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:7
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          knowledge

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          In search for therapies for solid tumors, companies turn to claudin
          In search for therapies for solid tumors, companies turn to claudin

          MollyFergusonforSTATOnTargetisarecurringfeaturefromSTATthatdivesdeepintothemostpromisingdrugtargetsi

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          AstraZeneca loses challenge to Medicare drug price negotiation

          ANDREWYATES/AFPviaGettyImagesWASHINGTON—AfederaljudgeinDelawareonFridayruledagainstAstraZenecainacas